Anne Cornelissen
Anne Cornelissen publishes mostly in Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, on topics such as Coronary Interventions and Diagnostics, Peripheral Artery Disease Management and Cardiac Imaging and Diagnostics.
- World rank
- #688,236 of 7,710,434 ranked researchers
- Rank in United States
- #233,037 of 1,627,098
- Works
- 90
- Citations
- 2.8k
- Citations per work
- 31.1
What does Anne Cornelissen research?
Anne Cornelissen's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences5864.9%
- Medicine5864.9%
- Everything else2426.5%
- Life Sciences88.6%
- 1Surgery33% of their works
- 2Cardiology and Cardiovascular Medicine17% of their works
- 3Pulmonary and Respiratory Medicine9% of their works
- 4Radiology, Nuclear Medicine and Imaging6% of their works
- 5Molecular Biology6% of their works
- 6Genetics3% of their works
Research topics
- Coronary Interventions and Diagnostics
- Peripheral Artery Disease Management
- Cardiac Imaging and Diagnostics
- Antiplatelet Therapy and Cardiovascular Diseases
- Cerebrovascular and Carotid Artery Diseases
- Lipoproteins and Cardiovascular Health
- Cardiac Valve Diseases and Treatments
- Angiogenesis and VEGF in Cancer
Which keywords describe Anne Cornelissen's research?
The keywords of their largest research topics: Atherosclerosis, Percutaneous Coronary Intervention, Coronary Stents, Myocardial Revascularization, Guidelines, Magnetic Resonance Imaging, Peripheral Arterial Disease and Cardiac Imaging.
- VEGF
- Surgical Aortic-Valve Replacement
- Endarterectomy
- Carotid Artery Stenosis
- Aspirin
- Cardiac Imaging
- Magnetic Resonance Imaging
- Myocardial Revascularization
- Percutaneous Coronary Intervention
- Atherosclerosis
- Coronary Stents
- Guidelines
- Peripheral Arterial Disease
- Coronary Artery Disease
- Clopidogrel
- Cholesterol-lowering
- Statins
- Transcatheter Aortic-Valve Replacement
- endothelial progenitor cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Atherosclerosis632 topics
- Percutaneous Coronary Intervention532 topics
- Coronary Stents431 topic
- Myocardial Revascularization431 topic
- Guidelines201 topic
- Magnetic Resonance Imaging202 topics
- Peripheral Arterial Disease201 topic
- Cardiac Imaging121 topic
- Coronary Artery Disease121 topic
- Aspirin101 topic
- Clopidogrel101 topic
- Carotid Artery Stenosis81 topic
- Cholesterol-lowering81 topic
- Endarterectomy81 topic
- Statins81 topic
- Surgical Aortic-Valve Replacement71 topic
- Transcatheter Aortic-Valve Replacement71 topic
- VEGF61 topic
- endothelial progenitor cells61 topic
Where does Anne Cornelissen work?
Anne Cornelissen's main affiliation in the publication record is CVPath Institute, United States.
How many publications and citations does Anne Cornelissen have?
OpenAlex counts 90 works and 2,803 citations for Anne Cornelissen, an h-index of 25, ranking #688,236 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anne Cornelissen. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.